• Crestor
• Banned
• Cardiomyopathy
• Cases
• Cholesterol
• Class Action
• Concerns
• Dangers
• Deaths
• Diabetes
• Heart Failure
• Heart Failure Lawsuit
• Heart Failure Lawyer
• Heart Problems
• Kidney Failure
• Kidney Pain
• Lawsuit
• Leg Pain
• Liver Damage
• Liver Failure
• Medication
• Muscle Damage
• Muscle Pain
• News
• Patient Information
• Problem
• Recall
• Renal Failure
• Rhabdomyolysis
• Risk
• Safety
• Side Effects
• Statin Drug
• Warning
• Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Data suggests there might be a link between the cholesterol medication Crestor and cardiomyopathy. Further research will need to be done to determine a cause and effect relationship, however, if you have experienced cardiomyopathy or another heart problem and have a history of taking Crestor, we may be able to help you.

Contact us for more information.

About Cardiomyopathy

Cardiomyopathy is a serious disease that affects the heart muscle and keeps it from working properly. There are two classifications of cardiomyopathy, primary and secondary. In patients with primary cardiomyopathy, the cause is not determined. In patients with secondary cardiomyopathy, a cause is determined and is often associated with other diseases that affect other organs in addition to the heart.

There are three types of cardiomyopathy, dilated, hypertrophic and restrictive.

Dilated (Congestive) Cardiomyopathy

Dilated cardiomyopathy, the most common type of cardiomyopathy, affects the heart cavity. The heart cavity will be stretched and enlarged (dilated). This condition can lead to more severe conditions, including:

• Heart failure
• Abnormal heart rhythms
• Blood clots and pulmonary embolism

Treatment for dilated cardiomyopathy usually aims at treating the cause of the problem. In some cases a heart transplant w ill be considered.

Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy affects the muscle mass of the left ventricle. The enlarged centricle obstructs the flow of blood from the left ventricle and can cause the valve to leak. One in 500 people are affected by hypertrophic cardiomyopathy; it is the most common form of inherited heart defects in the U.S.

Symptoms of hypertrophic cardiomyopathy include:

• Shortness of breath
• Chest pain
• Dizziness
• Fainting

Patients with this type of heart problem will usually be treated with a type of drug called a beta clocker or a calcium blocker. Patients that experience abnormal heart rhythms will be given medication for that as well. Surgery might be considered.

Restrictive Cardiomyopathy

Restrictive Cardiomyopathy is the term used to describe a condition in which the heart muscle becomes rigid. This is the least common form. Symptoms usually include:

• Swollen glands and feet
• Difficulty breathing upon exertion
• Fatigue

Cardiomyopathy and Crestor

Data suggests there might be a connection between Crestor and other statins, drugs to treat cholesterol. Patients taking these drugs should see their doctor if they begin to experience any unusual symptoms.

Our Crestor heart injury lawyers are investigating this issue. We are available to investigate a potential Crestor cardiomyopathy claim on your behalf. For more information, please contact us today.

"Possible Crestor®-Heart Failure Link"

Some researchers believe the cholesterol medication Crestor® (rosuvastatin) can increase the severity of heart failure in certain patients.

Coenzyme Q10 (CoQ10), pro...

» Read More

"FDA rejects petition to ban Crestor"

The consumer advocacy group Public Citizen submitted a petition to the FDA a year ago asking the agency to immediately withdraw the anti-cholesterol drug Crestor, but the agency has denied its request.

Crestor belongs to a group of drugs ...

» Read More

"Asians taking Crestor may be at higher risk for rhabdomyolysis"

The FDA has announced that Crestor is being relabeled to add a warning that starter doses should be reduced in Asian-American patients, as well as some other higher risk patients.

A clinical trial found that levels in Asian patients were d...

» Read More